Myocardin is a muscle-restricted transcriptional coactivator that activates a serum response factor (SRF)-dependent gene program required for cardiogenesis and embryonic survival. To identify myocardin-dependent functions in smooth muscle cells (SMCs) during postnatal development, mice harboring a SMC-restricted conditional, inducible Myocd null mutation were generated and characterized. Tamoxifen-treated SMMHC-Cre ERT2 /Myocd F/F conditional mutant mice die within 6 mo of Myocd gene deletion, exhibiting profound derangements in the structure of great arteries as well as the gastrointestinal and genitourinary tracts. Conditional mutant mice develop arterial aneurysms, dissection, and rupture, recapitulating pathology observed in heritable forms of thoracic aortic aneurysm and dissection (TAAD). SMCs populating arteries of Myocd conditional mutant mice modulate their phenotype by down-regulation of SMC contractile genes and up-regulation of extracellular matrix proteins. Surprisingly, this is accompanied by SMC autonomous activation of endoplasmic reticulum (ER) stress and autophagy, which over time progress to programmed cell death. Consistent with these observations, Myocd conditional mutant mice develop remarkable dilation of the stomach, small intestine, bladder, and ureters attributable to the loss of visceral SMCs disrupting the muscularis mucosa. Taken together, these data demonstrate that during postnatal development, myocardin plays a unique, and important, role required for maintenance and homeostasis of the vasculature, gastrointestinal, and genitourinary tracts. The loss of myocardin in SMCs triggers ER stress and autophagy, which transitions to apoptosis, revealing evolutionary conservation of myocardin function in SMCs and cardiomyocytes. Mice harboring a null mutation in the myocardin gene (Myocd) exhibit a block in cardiomyocyte proliferation accompanied by a dramatic increase in cardiomyocyte apoptosis, leading to lethality at midgestation (5). Ablation of Myocd in the adult heart leads to heart failure and lethality attributable to a disruption in sarcomere structure accompanied by programmed cell death (6). By contrast, mice harboring a neural crest-restricted ablation of Myocd die in the perinatal period from patent ductus arteriosus (PDA) attributable to a block in the SMC contractile gene program (7).
Edited by Harry C. Dietz, Johns Hopkins University School of Medicine, Baltimore, MD, and approved February 27, 2015 (received for review October 23, 2014) Myocardin is a muscle-restricted transcriptional coactivator that activates a serum response factor (SRF)-dependent gene program required for cardiogenesis and embryonic survival. To identify myocardin-dependent functions in smooth muscle cells (SMCs) during postnatal development, mice harboring a SMC-restricted conditional, inducible Myocd null mutation were generated and characterized. Tamoxifen-treated SMMHC-Cre ERT2 /Myocd F/F conditional mutant mice die within 6 mo of Myocd gene deletion, exhibiting profound derangements in the structure of great arteries as well as the gastrointestinal and genitourinary tracts. Conditional mutant mice develop arterial aneurysms, dissection, and rupture, recapitulating pathology observed in heritable forms of thoracic aortic aneurysm and dissection (TAAD). SMCs populating arteries of Myocd conditional mutant mice modulate their phenotype by down-regulation of SMC contractile genes and up-regulation of extracellular matrix proteins. Surprisingly, this is accompanied by SMC autonomous activation of endoplasmic reticulum (ER) stress and autophagy, which over time progress to programmed cell death. Consistent with these observations, Myocd conditional mutant mice develop remarkable dilation of the stomach, small intestine, bladder, and ureters attributable to the loss of visceral SMCs disrupting the muscularis mucosa. Taken together, these data demonstrate that during postnatal development, myocardin plays a unique, and important, role required for maintenance and homeostasis of the vasculature, gastrointestinal, and genitourinary tracts. The loss of myocardin in SMCs triggers ER stress and autophagy, which transitions to apoptosis, revealing evolutionary conservation of myocardin function in SMCs and cardiomyocytes.
smooth muscle cell | transcriptional coactivator | autophagy | ER stress | apoptosis T he unique physiology and contractile properties of smooth muscle cells (SMCs) underlie their capacity to regulate arterial tone as well as gastrointestinal and genitourinary function. In contrast to striated muscle cells, SMCs maintain the capacity to proliferate and modulate their phenotype from a contractile to a synthetic state during postnatal development (for review, see ref. 1) . The myocardin family of transcriptional coactivators (MRTFs), which includes myocardin, MKL-1/MRTF-A, and MKL-2/MRTF-B, are coexpressed in cardiomyocytes and SMCs, where they transduce signals from RhoA through the actin cytoskeleton, activating a subset of SRF-dependent genes encoding contractile and cytoskeletal elements (for review, see refs. 2-4). Mice harboring a null mutation in the myocardin gene (Myocd) exhibit a block in cardiomyocyte proliferation accompanied by a dramatic increase in cardiomyocyte apoptosis, leading to lethality at midgestation (5) . Ablation of Myocd in the adult heart leads to heart failure and lethality attributable to a disruption in sarcomere structure accompanied by programmed cell death (6) . By contrast, mice harboring a neural crest-restricted ablation of Myocd die in the perinatal period from patent ductus arteriosus (PDA) attributable to a block in the SMC contractile gene program (7) .
After more than a decade of study, fundamental questions regarding the function of myocardin in vascular SMCs during postnatal development as well as visceral SMCs populating the gastrointestinal and genitourinary tracts remain unanswered. Is myocardin required for SMC contractile gene expression and maintenance of arterial tone? What role, if any, does myocardin play in regulating expression of SRF-regulated SMC contractile genes in visceral SMCs? Do the related transcriptional coactivators MKL-1 and/or MKL-2 mediate redundant functions with myocardin in the adult vasculature or visceral tissues (4)? Is myocardin required for survival of vascular SMCs in a manner analogous to that it plays in cardiomyocytes (7)? Is the loss of myocardin associated with predisposition to vascular proliferative syndromes including atherosclerosis and/or aortic aneurysm and dissection? In this regard, it is noteworthy that mutation in the SRF-activated genes ACTA2, MYH11, and MYLK are associated with heritable forms of TAAD (for review, see ref. 8) .
In this report, we generated and characterized mice in which the Myocd gene was conditionally ablated in SMCs populating the adult vasculature and visceral tissues. Ablation of Myocd leads to profound defects in the structure of arteries as well as the gastrointestinal and genitourinary tracts. In the vasculature, this is accompanied by cell autonomous loss of the contractile
Significance
Smooth muscle cells (SMCs) play critical roles in maintaining organismal homeostasis. Myocardin is a muscle-restricted transcriptional coactivator previously implicated in development of the heart and vasculature. To define myocardin-mediated functions during postnatal development, we generated mice harboring an inducible, SMC-restricted mutation in the Myocd gene. Myocardin mutant mice exhibit profound derangements in arterial structure and in the gastrointestinal and genitourinary tracts. Myocd deletion leads to the loss of the contractile SMC phenotype, triggering cell-autonomous ER stress, autophagy, and apoptosis. These data reveal that myocardin is required for maintenance, homeostasis, and ultimately survival of vascular and visceral SMCs during postnatal development. These findings provide unanticipated insights into the pathogenesis of thoracic aortic aneurysm and dissection and gastrointestinal and genitourinary syndromes.
gene program that occurs coincident with activation of endoplasmic reticulum (ER) stress and the autophagic program. However, over time, myocardin-deficient vascular SMCs undergo programmed cell death. These data provide conclusive evidence that myocardin is required for homeostasis of the vasculature and visceral tissues during postnatal development. Moreover, these data demonstrate that loss of myocardin in the postnatal vasculature triggers autophagy, which transitions to apoptosis and cell death. (Fig. 1A) . By contrast, no deaths were observed in tamoxifen-treated Myocd F/F control mice over 10 mo (n = 60) (Fig.  1A ). These data demonstrate that SMC expression of myocardin is required for survival of adult mice and expression of the closely related Mkl-1 and Mkl-2 genes cannot compensate for the loss of myocardin in SMCs during postnatal development. Fig. S2 A and B) . High-resolution echocardiographic analysis revealed that the mean diameter of the proximal aorta was 2.14 ± 0.12 mm in tamoxifen-treated SMMHC-Cre ERT2 /Myocd F/F mice versus 1.74 ± 0.09 mm in control mice (P < 0.05) (Fig. S2 C and D) . Histological examination of the aorta 4 mo following tamoxifen treatment of conditional mutant (n = 10) and Myocd F/F control (n = 10) mice revealed medial (arrow) disarray with apparent SMC loss in the mutant arteries (compare Fig. 1C with Fig. 1D) . Loss of the characteristic spindle-like vascular SMC morphology was observed in all tamoxifen-treated conditional mutant arteries (Fig. 1D ) compared with controls (Fig. 1C) . Thrombosis, aneurysm, dissection with formation of false arterial lumen (arrow), and arterial rupture were variably observed in the aorta, carotid, and pulmonary arteries (compare Fig. 1E with Fig. 1 F and G) .
Results

Generation of Mice
In addition to changes in the vasculature, gross structural derangements were observed throughout the gastrointestinal and genitourinary tracts of tamoxifen-treated SMMHC-Cre ERT2 / Myocd F/F mutant mice ( Fig. 1 H-P) . Four months following tamoxifen exposure, dilation of the stomach (Fig. 1H) , small intestine (Fig. 1K), and bladder (Fig. 1N) was observed. Histologically, profound atrophy and disruption of the muscularis mucosa layer (arrows) developed in each of these visceral tissues (Fig. 1 I, J , L, M, O, and P). This was accompanied by the obvious loss of SMCs with separation within the muscularis mucosa of the stomach, intestine, and bladder of conditional Myocd mutant mice (Fig. 1 J, M, and P).
Myocardin Is Required for Maintenance of the Smooth Muscle Contractile
Phenotype in Vascular and Visceral SMCs. As anticipated, robust expression of smooth muscle actin (SMA), smooth muscle myosin heavy chain (SMMHC), SM22α, calponin-h1, and myosin light chain kinase (MLCK) was observed in medial SMCs populating the aorta of tamoxifen-treated Myocd F/F control mice ( Fig. 2 A-E). By contrast, 4 mo following tamoxifen exposure, near absence of these SMC contractile proteins was observed in SMMHC-Cre ERT2 / Myocd F/F SMCs populating the aorta ( Fig. 2 F-J) . qRT-PCR analyses confirmed that 4 mo following tamoxifen exposure, myocardin mRNA decreased by 85% in conditional mutant versus control mice ( Fig. 2 K and L) . Moreover, expression of the SMMHC, SM22α, SMA, caldesmon, and calponin genes decreased by 80-90% compared with aortas harvested from control mice ( Fig.  2 K and L) .
To examine whether expression of extracellular matrix (ECM) proteins compensated, at least in part, for the loss of SMC contractile proteins, we assessed fibrosis and expression of ECM in aortic sections harvested 4 mo following tamoxifen treatment of control ( (Fig. 2Q ). Of note, no difference in adventitial fibrosis was observed between control and mutant mice. Staining for tropoelastin (black stain) revealed no differences in expression in tamoxifen-treated control and conditional Myocd F/F mutant mice with generalized preservation of lamellar organization (Fig. 2 N and R) . However, a marked increase in fibronectin and laminin expression was observed in tamoxifentreated SMMHC-Cre Fig. 2 W and X) . In addition, abundant fibrinous collagen (Col) was observed in tamoxifen-treated conditional mutant mice (Fig. 2X) . Although it was difficult to appreciate due to the obvious loss of SMCs, expression of SMMHC and SMA appeared to be down-regulated in the muscularis mucosa layer of the stomach, small intestine, and bladder of tamoxifen-treated conditional mutant mice (Fig. S3) . Taken together, these data reveal that during postnatal development, myocardin is required for maintenance of the contractile SMC phenotype and the loss of myocardin is accompanied by the induction of ECM proteins.
Loss of Myocardin Triggers Autophagy in Aortic SMCs. To examine whether the loss of myocardin activates a stress-induced autophagy program, aortic sections harvested from conditional mutant and control mice 14 d posttamoxifen exposure were immunostained for a panel of autophagy markers (Fig. 3 A-J) (9, 10) . 3F) but not Myocd F/F controls (Fig. 3A) . Similarly, autophagy-related /Myocd F/F mutant mice ( Fig. 3 G and H) , but not in control mice (compare Fig. 3B with Fig. 3C ). Moreover, microtubule-associated protein 1 light chain 3 (LC3) and p62, or sequestosome 1, were dramatically up-regulated in arteries of conditional mutant mice (green stain, compare Fig.  3 D and E with Fig. 3 I and J) . qRT-PCR revealed 3-10-fold induction of ATG5, ATG7, Beclin-1, LC3a, and LC3b gene expression in the aorta of tamoxifen-treated SMMHC-Cre ERT2 / Myocd F/F mice (n = 3) compared with the expression of these genes in Myocd F/F control mice (n = 3) (P < 0.05) (Fig. 3 K and L) . Fourteen days following tamoxifen treatment, electron microscopy revealed abundant myofibers and mitochondria (white arrows) in medial SMCs populating the aorta of Myocd F/F control mice ( Fig. 3 M and N) . By contrast, a generalized loss of myofibers accompanied by formation of electron-dense structures resembling autophagosomes with embedded membranes and organelles (arrows) were observed in SMCs populating the aorta of SMMHCCre ERT2 /Myocd F/F mutant mice (Fig. 3 O and P) .
Loss of Myocardin Induces Cell Autonomous Autophagy. To distinguish whether SMC autophagy results from the cell autonomous loss of myocardin versus hemodynamic or other systemic stress, primary cultures of mouse aortic SMCs harvested from Myocd F/F conditional mutant mice were infected with a replication-defective adenovirus encoding Cre (Ad-Cre) or the control virus Ad-LacZ encoding β-galactosidase. Western blot analysis confirmed that myocardin protein decreased by 90% in SMC cultures infected with Ad-Cre relative to levels of myocardin expression observed in Ad-LacZ-infected cells (Fig. 4G) . Remarkably, 48 h postinfection in cells expressing Cre recombinase (red stain, Fig. 4 A-C), dramatic induction of ATG5, ATG7, and LC3 (green stain) was observed (Fig. 4 D-F) . Consistent with these data, immunoblot analysis revealed robust induction of Beclin-1, ATG5, ATG7, and LC3 in Ad-Cre-transduced Myocd F/F vascular SMCs (Fig. 4G) .
Myocd Deletion Activates ER Stress and Unfolded Protein Response in
Isolated Aortic SMCs. Electron microscopy of tamoxifen-treated SMMHC-Cre ERT2 /Myocd F/F aortic SMCs revealed dilation of the ER (Fig. S4) , suggesting the activation of the ER stress pathway (for review, see refs. 11, 12). To examine the hypothesis that the ER stress pathway or unfolded protein response (UPR) is activated in response to the loss of myocardin, we surveyed the expression of mediators of ER stress in Ad-Cre-and control Ad-LacZ-transduced Myocd F/F primary aortic SMCs. At 48 h postinfection, a dramatic induction of phosphorylated PERK was observed in Ad-Cre-but not Ad-LacZtransduced SMCs (Fig. 4 H and M) . Consistent with this observation, phosphorylated cytoplasmic eIF-2a (green stain), which is phosphorylated by PERK coupling ER stress to accumulation of protein, was observed in Ad-Cre-transduced SMCs (Fig. 4 I and N) . As anticipated, in response to phosho-eIF-2a, ATF4 (green stain) was upregulated in the nucleus of Ad-Cre-but not Ad-LacZ-transduced SMCs (Fig. 4 J and O) . Moreover, CHOP (green stain), which is induced in response to ER stress and promotes apoptosis, was observed in Ad-Cre-but not Ad-LacZ-transduced SMCs (Fig. 4 K  and P) . In addition, nuclear-spliced XBP-1 (green stain) was also observed in Ad-Cre-but not in Ad-LacZ-transduced SMCs (Fig. 4 L  and Q) . Finally, it is noteworthy that comparable levels of mTOR and AMP kinase expression, which operate both upstream and downstream of ER stress signals (13) , were observed in Ad-Cre-and AdLacZ-transduced Myocd F/F SMCs.
Late-Stage Induction of Apoptosis in Vascular SMCs. Autophagy may serve to preserve energy homeostasis within the cell, but under certain conditions, cell stress may induce programmed cell death (9, 10). To examine this question, we surveyed expression of apoptotic markers 14 d and 4 mo following tamoxifen exposure. Surprisingly, 14 d following tamoxifen exposure, nuclear TUNEL staining (green) indicative of apoptosis was not observed in medial SMCs populating the aorta of SMMHC-Cre ERT2 /Myocd F/F mutant or control mice (Fig. 5 A and F) . By contrast, 4 mo following tamoxifen exposure, a dramatic induction of TUNELpositive SMCs populating the aorta was observed in SMMHCCre ERT2 /Myocd F/F mutant mice compared with Myocd F/F control mice (Fig. 5 B and G) . The apoptotic index (percentage medial SMCs with TUNEL-positive nuclei) was 22.1 ± 0.01% in mutant mice compared with 3.99 ± 0.01% in controls (P < 0.01). Interestingly, focal patches of TUNEL-positive cells were often observed following tamoxifen treatment of SMMHC-Cre ERT2 / Myocd F/F mutant mice (Fig. S5 B-D and F-H) but not in controls ( Fig. S5 A and E) . Consistent with these findings, 4 mo following tamoxifen exposure, abundant caspase 3 and caspase 9 (arrows) were observed in SMCs of tamoxifen-treated SMMHC-Cre ERT2 / Myocd F/F mutant mice, demonstrating activation of the intrinsic/ mitochondrial apoptotic pathway (Fig. 5 C, D, H, and I) . Moreover, p53, a major orchestrator of cellular response to stress, was induced in medial SMCs of tamoxifen-treated conditional mutant mice (Fig. 5 E and J) . Consistent with these observations, 4 mo following tamoxifen treatment, EM revealed widespread SMC apoptosis manifest as nuclear (N) chromatin aggregation (arrows), nuclear fragmentation, and cytoplasmic apoptotic body (AB) formation in tamoxifen-treated SMMHC-Cre ERT2 /Myocd F/F mutant mice (Fig. 5 M and N) . By contrast, preserved nuclear architecture with diffuse chromatin and abundant myofibers was observed in SMCs populating the aorta of tamoxifen-treated Myocd F/F control mice ( Fig. 5 K and L) .
Discussion
The data described in this report demonstrate a unique, and important, function of the muscle-restricted transcriptional coactivator, myocardin, during postnatal development in the vasculature and visceral tissues. In the aorta and other arteries, Myocd deletion leads to disruption of the tunica media, dilation of the thoracic aorta, aneurysm, and dissection. In the gastrointestinal and genitourinary tract, disruption and atrophy of the muscularis mucosa is observed leading to dilation of the stomach, intestine, bladder, and ureters. In both vascular and visceral SMCs, the loss of myocardin causes a profound block in the expression of SMC contractile genes and proteins. This is surprising, as Srf, Mkl-1, and Mkl-2 are expressed and induced in tamoxifen-treated Myocd conditional mutant mice, suggesting strongly that myocardin is the sole MRTF member capable of activating the repertoire of SRF-dependent SMC genes during postnatal development. Moreover, we believe that this is the first direct evidence that myocardin regulates the contractile phenotype in visceral SMCs populating the gastrointestinal and urinary tracts.
Remarkably, hours to days following ablation of Myocd, SMCs activate an autophagic program manifested by expression of Beclin-1, ATG5, ATG7, and LC3. Early and late autophagosomes containing organelles were observed in vascular SMCs (Fig. 3) . Of note, autophagy was not only observed in the vasculature of Myocd conditional mutant mice but also in Myocddeficient isolated vascular SMCs (Fig. 4) . The observation that multiple markers of ER stress/UPR were induced following the ablation of Myocd in aortic SMCs suggests strongly that ER stress/UPR may contribute to the activation of the autophagic program. Activation of autophagy occurred coincident with the loss of myocardin, raising the intriguing hypothesis that modulation of the vascular SMC phenotype (and repression of SMC contractile genes) may be accelerated by ER stress-induced autophagy of SMC contractile elements required to preserve cellular energy stores and metabolism. Consistent with a model wherein turnover of SMC contractile proteins triggers ER stressinduced autophagy, overexpression of SMMHC led to the activation of UPR and autophagic turnover in vascular SMCs (14) . However, late-stage SMC apoptosis was observed, suggesting that induction of autophagy is ultimately not sufficient to preserve vascular (and visceral) SMCs required for cardiovascular homeostasis and function of visceral tissues.
Remarkably, within weeks of Myocd deletion, all tamoxifentreated SMMHC-Cre ERT2 /Myocd F/F mutant mice developed dilation of the ascending aorta and aortic arch, recapitulating pathologies observed in TAAD patients. As such, these findings provide insights into the pathogenesis of heritable causes of TAAD (8) . Ten to fifteen percent of TAAD patients exhibit a heterozygous mutation in the myocardin target gene ACTA2 or MYH11 (15, 16) . MYH11 mutations are identified primarily in families with TAAD inherited in association with a PDA (17) . Consistent with this observation, mice harboring a neural crest-restricted deletion of Myocd succumb within the perinatal period from hypoxia attributable to PDA (17) . Taken together, these data implicate the loss of myocardin-activated SMC contractile genes in development of thoracic aortic dissection and aneurysms observed in Myocd conditional mutant mice. The association of focal patches of apoptosis in the aorta of tamoxifen-treated SMMHC-Cre ERT2 /Myocd F/F conditional mutant mice raises the intriguing hypothesis that mutations in the ACTA2 and/or MYH11 genes may initially only lead to dilation of the thoracic aorta, but over time in response to hemodynamic or prolonged ER stress result in medial SMC apoptosis, leading to aortic dissection and its associated morbidities. The accompanying disruption of the muscularis mucosa throughout the gastrointestinal and genitourinary tracts provides, to our knowledge, the first direct evidence that myocardin lies upstream in a transcriptional program required for maintenance of the SMC contractile phenotype in visceral SMCs. We speculate that as in vascular SMCs, the gross alterations in visceral tissues are, at least in part, attributable to the loss of SRF/myocardinactivated SMC contractile genes. In support of this model, MYH11-deficient mice demonstrated vascular complications as well as dysfunction of bladder and intestine (18, 19) . Moreover, de novo mutations in ACTA2 causes multisystem smooth muscle dysfunction that includes aortic and cerebrovascular disease, fixed dilated pupils, hypotonic bladder, malrotation, and hypoperistalsis of the gut (20) . Taken together, these observations suggest that further study of mutations in genes encoding SMC contractile proteins may provide new insights into gastrointestinal and genitourinary syndromes, including esophageal reflux, gastrointestinal dysmotility syndromes, irritable bowel syndromes, and bladder dysmotility.
Methods
Generation of Mice Containing a SMC-Restricted Mutation in the Myocd Gene. Genetically engineered mice harboring a conditional null mutation in the Myocd gene (Myocd Echocardiography and Micro-CT Imaging. Transthoracic echocardiography was performed as described previously (6) . Analyses of left ventricular mass and volume, ejection fraction (EF %), and fraction shortening (FS %) were performed using standard 2D quantification methods by following the guidelines of the America Society of Echocardiography (22) . Micro-CT imaging was performed on an eXplore Locus SP specimen scanner as described (GE Healthcare) (21) . Scan protocol included 80 keV, 80 μA, 250-μm Al filter, short-scan (Parker) method, 500 views at 0.4°steps, four averages, 8 × 8 × 8 μm 3 reconstruction voxel, and 3.5-h scan time. Image data were analyzed with MicroView (GE Healthcare), ImageJ (National Institutes of Health), and OsiriX software.
Histology, Immunohistochemistry, and Electron Microscopy. Histology, immunohistochemistry, and electron microscopy were performed as described previously (7) . Immunohistochemistry protocols are available at www.pennmedicine. org/heart/research-clinical-trials/core-facilities/histology-gene-expression/. Antibodies used for immunohistochemistry studies are included in Table S1 .
Real-Time qRT-PCR and Western Blot Analysis. qRT-PCR was performed using the DNA Engine Opticon 2 Real Time Detection System (Bio-Rad Laboratories, Inc.) as described previously (23) . Western blot analyses were performed and quantified as described previously (7). Antibodies are described in Table S1 .
RdAV Transduction of SMCs and Quantification of Autophagy. Primary cultures of mouse aortic SMCs were isolated from 1-mo-old Myocd F/F conditional mutant mice as described previously (24) . Early (<4) passage vascular SMCs were used in the autophagy and ER stress experiments. Triplicate cultures of vascular SMCs were grown in low serum medium (DMEM containing 0.5% FBS and 0.3% horse serum) for 24 h and infected with (10 multiplicity of infection) Ad-LacZ or Ad-Cre as described previously (24) . At 48 h posttransduction, triplicate cultures were harvested for protein assays or immunostaining as described previously (7, 24) . Experiments were repeated three times to ensure reproducibility.
Statistical Considerations. Comparison of survival rates was performed by Kaplan-Meier analysis with PRISM software (GraphPad). All measurement data are expressed as mean ± SEM. The statistical significance of differences between groups was determined by Student's t test. Differences were considered significant at a P value < 0.05.
